Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -41.05M
March 31, 2026 -40.16M
December 31, 2025 -40.75M
September 30, 2025 -38.98M
June 30, 2025 -39.43M
March 31, 2025 -41.57M
December 31, 2024 -40.50M
September 30, 2024 -40.45M
June 30, 2024 -38.17M
March 31, 2024 -40.94M
December 31, 2023 -39.61M
September 30, 2023 -42.52M
Date Value
June 30, 2023 -45.72M
March 31, 2023 -42.91M
December 31, 2022 -43.36M
September 30, 2022 -40.00M
June 30, 2022 -38.02M
March 31, 2022 -34.71M
December 31, 2021 -28.92M
September 30, 2021 -25.55M
June 30, 2021 -21.44M
March 31, 2021 -16.95M
December 31, 2020 -16.41M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
NeuroPace, Inc. -11.61M
Accuray, Inc. -19.26M
Micron Solutions, Inc. --
Orthofix Medical, Inc. -26.93M
ResMed, Inc. 1.629B